俞一飞

获奖荣誉

2016华夏垂体疾病多学科高峰论坛青年医师论文演讲/病例分享比赛 一等奖

科研成果

【发表中文文献】
1、生长抑素类似物对不合并糖尿病的垂体生长激素瘤患者糖代谢的作用及相关因素分析 中华糖尿病杂志 2021,13(1) 54-59 10.3760/cma.j.cn115791-20200708-00427
2、2021 ENDO年会：垂体疾病专题会议纪要 国际内分泌代谢杂志 2021,41(3) 253-255 10.3760/cma.j.cn121383-20210414-04041
3、第3代促甲状腺素受体抗体测定法(Elecsys)对甲状腺毒血症的鉴别诊断价值 中国临床医学 2021, 28(1) 80-84 10.12025/j.issn.1008-6358.2021.20201871
4、2型糖尿病合并慢性肾脏病且尿白蛋白正常者脉搏波传导速度变化及其危险因素分析 中华糖尿病杂志 2020, 12(10) 772-777 10.3760/cma.j.cn115791-20200624-00397
5、垂体生长激素腺瘤患者糖代谢异常特点及经蝶手术对其影响 中华糖尿病杂志 2019,11(9)610-615 10.3760/cma.j.issn.1674-5809.2019.09.009
6、2型糖尿病患者代谢性炎症综合征与高敏C反应蛋白的相关性研究 中国糖尿病杂志 2018, 26(7) 577-580 10.3969/j.issn.1006-6187.2018.07.010
7、住院2型糖尿病合并正常白蛋白尿的慢性肾脏病患者临床特征及危险因素分析 中华糖尿病杂志 2018,10(4) 269-273 10.3760/cma.j.issn.1674-5809.2018.04.007
【发表英文文献】
1、Treatment of acromegaly by rosiglitazone via upregulating 15-PGDH in both pituitary adenoma and liver iScience. 2021 Aug 14;24(9):102983. 10.1016/j.isci.2021.102983
2、The association of erythrocyte sedimentation rate, high-sensitivity C-reactive protein and diabetic kidney disease in patients with type 2 diabetes BMC Endocr Disord. 2020 Jul 13;20(1):103. 10.1186/s12902-020-00584-7
3、High-Performance Liquid Chromatography-Mass Spectrometry-Based Lipid Metabolite Profiling of Acromegaly J Clin Endocrinol Metab. 2020 Mar 1;105(3):dgaa014 10.1210/clinem/dgaa014
4、Higher growth hormone levels are associated with erectile dysfunction in male patients with acromegaly
Endocr Pract. 2019 Jun;25(6):562-571.
5、Spironolactone Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Rats J Diabetes Res. 2018 Oct 14;2018:9232065 10.1155/2018/9232065
6、Islet Autoantibody Patterns in Patients With Type 2 Diabetes Aged 60 and Higher: A Cross-Sectional Study in a Chinese Hospital Front Endocrinol (Lausanne). 2018 May 25;9:260. 10.3389/fendo.2018.00260. eCollection 2018.
7、The comprehensive impact on human body induced by resolution of growth hormone excess Eur J Endocrinol. 2018 Apr;178(4):365-375 10.1530/EJE-17-0872

工作经历

教育经历